6 completed. 4 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
| Phase 2 | 2 | Completed 2 |
Follow URC102: new trials by email Literature Review of URC102 trials Research Report on URC102
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PK,PD and DDI of Epaminurad and Naproxen in Healthy Volunteers Epaminurad, Naproxen, Epaminurad, Epaminurad placebo - Healthy | Phase 1 | Completed | JW Pharmaceutical | 57 | 2024-06-03 | 2026-04-16 |
| A Safety, PK, PD and Food Effect Study of URC102 in Healthy Adults and Patients With Renal Impairment URC102 - Healthy, Renal Impairment | Phase 1 | Completed | JW Pharmaceutical | 28 | 2021-11-29 | 2022-12-06 |
| Study of URC102 to Assess the Safety and Efficacy in Gout Patients URC102, Placebo - Gout, Hyperuricemia | Phase 2 | Completed | JW Pharmaceutical | 76 | 2015-10-01 | 2017-01-10 |
| Phase 1 Study(Additional) of URC102 in Healthy Subjects Placebo, URC102 - Healthy | Phase 1 | Completed | JW Pharmaceutical | 21 | 2015-08-05 | 2020-02-13 |
| Phase 2 Study of URC102 to Assess the Efficacy and Safety in Gout Patients URC102 0.25mg, URC102 0.5mg, URC102 1.0mg - Gout, Hyperuricemia | Phase 2 | Completed | JW Pharmaceutical | 64 | 2014-07-24 | 2017-03-08 |
| Phase 1 Study of URC102 in Healthy Subjects URC102, Placebo - Healthy | Phase 1 | Completed | JW Pharmaceutical | 81 | 2013-05-23 | 2017-03-08 |
Gout (2) · Hyperuricemia (2) · Renal Insufficiency (1)
South Korea (6)
Howard Lee, MD, PhD (1) · Kyung-Sang Yu, MD, PhD, MBA (1) · Kyung-sang Yu, MD (1) · Min-kyu Park, MD (1)